Jump to content

User talk:Arion~enwiki: Difference between revisions

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
Content deleted Content added
Tawkerbot (talk | contribs)
m subst'ing test msgs per WP:SUBST
Ramaanand (talk | contribs)
No edit summary
Line 6: Line 6:


I deleted [[User:Arion/monobook.js]] since it was clearly meant to assist in moving articles to improper names. -- [[User:Jitse Niesen|Jitse Niesen]] ([[User talk:Jitse Niesen|talk]]) 11:32, 4 September 2005 (UTC)
I deleted [[User:Arion/monobook.js]] since it was clearly meant to assist in moving articles to improper names. -- [[User:Jitse Niesen|Jitse Niesen]] ([[User talk:Jitse Niesen|talk]]) 11:32, 4 September 2005 (UTC)
== Please put this on the Talk:Homeopathy Page and mention it is posted by me ==

Dear Scientizzle,<br>
Please put this on the Talk:Homeopathy Page and mention it is posted by me (or else the others may think I've bribed you); I'm not yet able to post there directly myself because the Page is semi-writeprotected.<br>
Here are some of the studies/clinical trials:-</p>
<b>
<p align="left">STUDIES OF THE ACTIVITY OF HOMEOPATHIC MEDICINES</p>
<div align="left">
<table height="172" width="678" border="1">
<tr>
<td width="171" height="9"><font size="1">ORIGINAL/TRANSLATED TITLE</font></td>
<td width="128" height="9">AUTHOR(S)</td>
<td width="84" height="9">PUBLICATION</td>
<td width="92" height="9">ACTIVITY</td>
<td width="203" height="9">STUDY</td>
</tr>
<tr>
<td width="171" height="9"><font face="Optima-Bold" size="1"><b>
<p align="left">Inhibition of lymphoblast</b></font></b> <font face="Optima-Bold" size="1"><b>transformation
test (LTT) in</b></font> <font face="Optima-Bold" size="1"><b>phytohaemagglutinin
(PHA) with</b></font> <font face="Optima-Bold" size="1"><b>Phytolacca
americana in</b></font> <b><font face="Optima-Bold" size="1">homeopathic
dilution</font></b></p>
</td>
<td width="128" height="9"><font face="Optima" size="1">
<p align="left">Colas H.,</p>
<p align="left">Aubin M.,</p>
<p align="left">Picard P.,</p>
<p align="left">Lebecq J.C.</font></p>
</td>
<td width="84" height="9"><i><font face="Optima-Oblique" size="1">
<p align="left">Ann. Homéopat.</p>
<p align="left">Fr.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1975</font></b><font face="Optima" size="1">,
6: 1-11.</font></p>
</td>
<td width="92" height="9"><b>
<p align="left"><font face="Optima-Bold" size="1">Inhibitory</font></b></p>
</td>
<td width="203" height="9">
<p align="left"><font face="Optima" size="1">Lymphoblast</p>
<p align="left">transformation</font></p>
</td>
</tr>
<tr>
<td width="171" height="9"><font face="Optima-Bold" size="1"><b>
<p align="left">Inquiry into the limits of biological</b></font> <font face="Optima-Bold" size="1"><b>effects
of chemical compounds in</b></font> <font face="Optima-Bold" size="1"><b>tissue
culture. I. Low dose effects of</b></font> <b><font face="Optima-Bold" size="1">mercure
chloride</font></b></p>
</td>
<td width="128" height="9"><font face="Optima" size="1">
<p align="left">Mansvelt J.D.,</p>
<p align="left">van Amons E.</font></p>
</td>
<td width="84" height="9">
<p align="left"><i><font face="Optima-Oblique" size="1">Z.
Naturtorschung</font></i><font face="Optima" size="1">,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">1975</font></b><font face="Optima" size="1">, 30:</p>
<p align="left">643-649.</font></p>
</td>
<td width="92" height="9"><b>
<p align="left"><font face="Optima-Bold" size="1">Inhibitory</font></b></p>
</td>
<td width="203" height="9"><font face="Optima" size="1">
<p align="left">Lymphocyte</p>
<p align="left">growth</font></p>
</td>
</tr>
<tr>
<td width="171" height="9"><b><font face="Optima-Bold" size="1">
<p align="left">The effects of Belladonna and</font></b> <font face="Optima-Bold" size="1"><b>Ferrum
phosphoricum on the</b></font> <font face="Optima-Bold" size="1"><b>chemoluminescence
of human</b></font> <b><font face="Optima-Bold" size="1">poly-morphonuclear
neutrophils</font></b></p>
</td>
<td width="128" height="9"><font face="Optima" size="1">
<p align="left">Poitevin B.,</p>
<p align="left">Aubin M.,</p>
<p align="left">Royer J.F.</font></p>
</td>
<td width="84" height="9"><i><font face="Optima-Oblique" size="1">
<p align="left">Ann. Homéop. Fr.</font></i><font face="Optima" size="1">,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">1983</font></b><font face="Optima" size="1">, 3: 5-12.</font></p>
</td>
<td width="92" height="9"><b>
<p align="left"><font face="Optima-Bold" size="1">Inhibitory</font></b></p>
</td>
<td width="203" height="9"><font face="Optima" size="1">Radical release</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Effect of aconitum and veratrum</p>
<p align="left">on the isolated perfused heart of</p>
<p align="left">the common eel </font></b><font face="Optima" size="1">(Anguilla
anguilla)</font></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Pennec J.P.,</p>
<p align="left">Aubin M.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Comp. Biochem.</p>
<p align="left">Physiol.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1984</font></b><font face="Optima" size="1">,</p>
<p align="left">776: 367-369.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">Aconitine toxicity</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Elements of homeopathic</p>
<p align="left">pharmacology</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Aubin M.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Homéopathie</p>
<p align="left">Franç.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1984</font></b><font face="Optima" size="1">,
72:</p>
<p align="left">231- 235</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">Aconitine toxicity</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">The effect of homeopathic</p>
<p align="left">preparations on the phagocyte</p>
<p align="left">activity of granulocytes. In vitro</p>
<p align="left">tests and double-blind controlled</p>
<p align="left">trials</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Wagner H.,</p>
<p align="left">Jurcic K.,</p>
<p align="left">Doenicke A.,</p>
<p align="left">Rosenhuber E.,</p>
<p align="left">Behrens N.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Arzneim.</p>
<p align="left">Forsch./Drug Res.</font></i><font face="Optima" size="1">,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">1986</font></b><font face="Optima" size="1">, 36:</p>
<p align="left">1424-1425.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">Phagocytosis</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Approach to quantitative analysis</p>
<p align="left">of the effect of Apis mellifica on</p>
<p align="left">the degranulation of human</p>
<p align="left">basophils cultivated in vitro</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Poitevin B.,</p>
<p align="left">Aubin M.,</p>
<p align="left">Benveniste J.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Innov. Tech. Biol.</p>
<p align="left">Med.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1986</font></b><font face="Optima" size="1">,
7:</p>
<p align="left">64-68.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Basophil</p>
<p align="left">degranulation</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">In vitro stimulation of human</font></b> <b><font face="Optima-Bold" size="1">granulocytes
and lymphocytes by</font></b> <font face="Optima-Bold" size="1"><b>pico-
and femtogram quantities of</b></font> <b><font face="Optima-Bold" size="1">cytostatic
agents</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Wagner H.,</p>
<p align="left">Kreher B.,</p>
<p align="left">Jurcic K.</font></p>
</td>
<td width="84" height="8"><font face="Optima-Oblique" size="1"><i>
<p align="left">Arzneim.</i></font> <b><font face="Optima-Oblique" size="1"><i>Forsch./Drug
Res.</i></font><font face="Optima" size="1">,</font></b> <b><font face="Optima-Bold" size="1">1988</font><font face="Optima" size="1">,
38:</font></b> <b><font face="Optima" size="1">273-275.</font></b></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Lymphocyte</p>
<p align="left">growth</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Human basophil degranulation</font></b> <b><font face="Optima-Bold" size="1">triggered
by very dilute antiserum</font></b> <b><font face="Optima-Bold" size="1">against
IgE</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Davenas E.,</font> <font face="Optima" size="1"><b>Beauvais
F.,</b></font> <font face="Optima" size="1"><b>Amara J.,</b></font> <font face="Optima" size="1"><b>Robinson
M.,</b></font> <font face="Optima" size="1"><b>Miadonna A.,</b></font> <font face="Optima" size="1"><b>Tedeschi
A.,</b></font> <font face="Optima" size="1"><b>Pomeranz B.,</b></font> <font face="Optima" size="1"><b>Fortner
P.,</b></font> <font face="Optima" size="1"><b>Belon P.,</b></font> <font face="Optima" size="1"><b>Sainte-Laudy
J.,</b></font> <font face="Optima" size="1"><b>Poitevin B.,</b></font> <b><font face="Optima" size="1">Benveniste
J.</font></b></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Nature</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1988</font></b><font face="Optima" size="1">,</p>
<p align="left">333: 816-818.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Basophils</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><font face="Optima" size="1">
<p align="left"></font><b><font face="Optima-Bold" size="1">In vitro
immunological</p>
<p align="left">degranulation of human basophils</p>
<p align="left">is modulated by lung histamine</p>
<p align="left">and Apis mellifica</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Poitevin B.,</p>
<p align="left">Davenas E.,</p>
<p align="left">Benveniste J.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Brit. J. Clin.</p>
<p align="left">Pharmacol.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1988</font></b><font face="Optima" size="1">,</p>
<p align="left">25: 439-444.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Basophil</p>
<p align="left">degranulation</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Cytotoxic agents as</p>
<p align="left">immunomodulators</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Wagner H.,</p>
<p align="left">Kreher B.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Proc. of the 3rd</p>
<p align="left">GIRI meeting</font></i><font face="Optima" size="1">,</p>
<p align="left">Paris, </font><b><font face="Optima-Bold" size="1">1989</font></b><font face="Optima" size="1">,
31-</p>
<p align="left">46.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Lymphocyte</p>
<p align="left">growth</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Contributions of fundamental</p>
<p align="left">research in homeopathy</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Boiron J.,</p>
<p align="left">Belon P.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Berl. J. Res. Hom.</font></i><font face="Optima" size="1">,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">1990</font></b><font face="Optima" size="1">, 1: 34-35.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Basophil</p>
<p align="left">degranulation</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Synergism of action between</p>
<p align="left">indoleacetic acid (IAA) and highly</p>
<p align="left">diluted solutions of CaCO3 on the</p>
<p align="left">growth of oat coleoptiles</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">Bornoroni C.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Berl. J. Res. Hom.</font></i><font face="Optima" size="1">,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">1991</font></b><font face="Optima" size="1">, 1 (4/5):</p>
<p align="left">275-278.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Growth of plant</p>
<p align="left">cells</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Study of the action of</p>
<p align="left">Hahnemannian dilutions of</p>
<p align="left">mercury chloride on the mitotic</p>
<p align="left">index in animal cell cultures.</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Boiron J.,</p>
<p align="left">Abecassis J.,</p>
<p align="left">Cotte J.,</p>
<p align="left">Bernard A.M.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Ann. Homéop.</p>
<p align="left">Fr</font></i><font face="Optima" size="1">., </font><b><font face="Optima-Bold" size="1">1991</font></b><font face="Optima" size="1">,
23:</p>
<p align="left">43-49.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">Hg toxicity</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Dual effects of formylpeptides on</p>
<p align="left">the adhesion of endotoxin-primed</p>
<p align="left">human neutrophils</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Bellavite P.,</p>
<p align="left">Chirumbolo S.,</p>
<p align="left">Lippi G.,</p>
<p align="left">Andrioli G.,</p>
<p align="left">Bonazzi L.,</p>
<p align="left">Ferro I.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Cell. Biochem.</p>
<p align="left">Funct.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1993</font></b><font face="Optima" size="1">,
11:</p>
<p align="left">231-239.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Cell adhesion</p>
<p align="left">(bact. pept.</p>
<p align="left">10-8-10-9)</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Effects of homeopathic</p>
<p align="left">preparations of organic acids and</p>
<p align="left">of minerals on the oxidative</p>
<p align="left">metabolism of human neutrophils</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Chirumbolo S.,</p>
<p align="left">Signorini A.,</p>
<p align="left">Bianchi I.,</p>
<p align="left">Lippi G.,</p>
<p align="left">Bellavite P.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Br. Hom. J.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1993</font></b><font face="Optima" size="1">,</p>
<p align="left">82: 227-244.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Leucocyte</p>
<p align="left">activation</p>
<p align="left">(metabolism)</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Platelets/endothelial cells</p>
<p align="left">interactions in presence of</p>
<p align="left">acetylsalicylic acid at ultra low</p>
<p align="left">dose</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Doutremepuich</p>
<p align="left">C.,</p>
<p align="left">Lalanne M.C.,</p>
<p align="left">Ramboer I.,</p>
<p align="left">Sertillanges</p>
<p align="left">M.N.,</p>
<p align="left">De Seze O.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Omeomed 92 (C.</p>
<p align="left">Bornoroni, ed.)</font></i><font face="Optima" size="1">,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">1993</font></b><font face="Optima" size="1">, Editrice</p>
<p align="left">Compositori,</p>
<p align="left">Bologna:</p>
<p align="left">109-115.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Prostacyclin</p>
<p align="left">release</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Effect of high dilutions of epidermal</p>
<p align="left">growth factor (EGF) on </font><i><font face="Optima-BoldOblique" size="1">in
vitro</p>
</font></i><font face="Optima-Bold" size="1">
<p align="left">proliferation of keratinocyte and</p>
<p align="left">fibroblast cell lines</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Fougeray S.,</p>
<p align="left">Moubry K.,</p>
<p align="left">Vallot N.,</p>
<p align="left">Bastide M.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Br. Hom. J.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1993</font></b><font face="Optima" size="1">,</p>
<p align="left">82: 124-125.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Growth of</p>
<p align="left">keratinocytes</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Effects of different homeopathic</p>
<p align="left">potencies of Lachesis on</p>
<p align="left">lymphocyte cultures obtained</p>
<p align="left">from rabbit blood</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Enbergs H.,</p>
<p align="left">Arndt G.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Biol. Tier., </font><b><font face="Optima-BoldOblique" size="1">1993</font></b><font face="Optima-Oblique" size="1">,</p>
<p align="left">4.</font></i></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Mitotic and</p>
<p align="left">immunostimulating</p>
<p align="left">activity (bact. pept</p>
<p align="left">10-5-10-6)</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">The effect of homeopathic</p>
<p align="left">potencies of housedust mite on</p>
<p align="left">the migration of house-dust sensitive</p>
<p align="left">human leukocytes</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Gibson S.L.,</p>
<p align="left">Gibson R.G.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Complement.</p>
<p align="left">Ther. Med.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1996</font></b><font face="Optima" size="1">,</p>
<p align="left">4: 169-171.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Leucocyte</p>
<p align="left">chemotaxis</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">The effects of Nux vomica</p>
<p align="left">Homaccord and Atropinum comp.</p>
<p align="left">on intestinal activity in vitro</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Kanui T.I.,</p>
<p align="left">Enbergs H.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Biol. Tier.</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1996</font></b><font face="Optima" size="1">/1,</p>
<p align="left">43-47.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Contraction of</p>
<p align="left">intestinal muscles</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Application of flow cytometry to</p>
<p align="left">the analysis of the</p>
<p align="left">immunosuppressive effect of</p>
<p align="left">histamine dilutions on human</p>
<p align="left">basophil action: effect of</p>
<p align="left">cimetidine</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Sainte-Laudy J.,</p>
<p align="left">Belon P.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Inflamm. Res</font></i><font face="Optima" size="1">.,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">1997</font></b><font face="Optima" size="1">, 46:</p>
<p align="left">S27-S28.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Basophil</p>
<p align="left">degranulation</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Effects of Podophillum pellatum</p>
<p align="left">compounds in various</p>
<p align="left">preparations and dilutions on</p>
<p align="left">human neutrophil functions in</p>
<p align="left">vitro</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Chirumbolo S.,</p>
<p align="left">Conforti A.,</p>
<p align="left">Lussignoli S.,</p>
<p align="left">Metelmann H.</p>
<p align="left">et Al.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Br. Hom. J</font></i><font face="Optima" size="1">., </font><b><font face="Optima-Bold" size="1">1997</font></b><font face="Optima" size="1">;</p>
<p align="left">86-16.</font></p>
</td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Inhibitory</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Release of</p>
<p align="left">superoxides</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><i><font face="Optima-BoldOblique" size="1">
<p align="left">In vivo </font></i><font face="Optima-Bold" size="1">and
</font><i><font face="Optima-BoldOblique" size="1">in vitro </font></i><font face="Optima-Bold" size="1">studies
on the</p>
<p align="left">efficiency of potentized and nonpotentized</p>
<p align="left">substances</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Harisch G.,</p>
<p align="left">Dittmann J.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">BT, </font></i><b><font face="Optima-Bold" size="1">1997</font></b><font face="Optima" size="1">,
2;</p>
<p align="left">40-46.</font></p>
</td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Difference between</p>
<p align="left">potentised and</p>
<p align="left">non-potentised</p>
<p align="left">substances</font></p>
</td>
<td width="203" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">In vivo </font></i><font face="Optima" size="1">and </font><i><font face="Optima-Oblique" size="1">in</p>
<p align="left">vitro </font></i><font face="Optima" size="1">study;
basic</p>
<p align="left">research</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Experiments with the effects of</p>
<p align="left">Ubichinon-Injeel and strong</p>
<p align="left">Ubichinon-Injeel on an acellular</p>
<p align="left">system</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Harisch G.,</p>
<p align="left">Dittmann J.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1997</font></b><font face="Optima" size="1">,
3;</p>
<p align="left">99-104.</font></p>
</td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Different effects of</p>
<p align="left">associations of</p>
<p align="left">various potencies and</p>
<p align="left">individual potencies</font></p>
</td>
<td width="203" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">In vitro </font></i><font face="Optima" size="1">study;</p>
<p align="left">basic research</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Efficacy of the homeopathic drugs</p>
<p align="left">Suis and Arnica comp.-Heel® on</p>
<p align="left">lymphocyte and phagocyte</p>
<p align="left">activity</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">Enbergs H.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1998</font></b><font face="Optima" size="1">,
1;</p>
<p align="left">3-11.</font></p>
</td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Effect of</p>
<p align="left">organotherapeutics</p>
<p align="left">and Arnica comp. -</p>
<p align="left">Heel® on immune</p>
<p align="left">system cells</font></p>
</td>
<td width="203" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">In vitro </font></i><font face="Optima" size="1">study;</p>
<p align="left">basic research</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Influence of dilutions and</p>
<p align="left">potencies of cAMP on different</p>
<p align="left">enzymatic systems</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Harisch G.,</p>
<p align="left">Dittmann J.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1998</font></b><font face="Optima" size="1">,
2;</p>
<p align="left">55-62.</font></p>
</td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Effects of dilutions</p>
<p align="left">and potencies of</p>
<p align="left">cAMP on some</p>
<p align="left">enzymatic activities</font></p>
</td>
<td width="203" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">In vitro </font></i><font face="Optima" size="1">study;</p>
<p align="left">basic research</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Studies of the principles of</p>
<p align="left">homeopathy; the changeover</p>
<p align="left">from </font><i><font face="Optima-BoldOblique" size="1">in
vivo </font></i><font face="Optima-Bold" size="1">to </font><i><font face="Optima-BoldOblique" size="1">in
vitro</p>
</font></i><font face="Optima-Bold" size="1">
<p align="left">experimental research</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Harisch G.,</p>
<p align="left">Dittmann J.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1998</font></b><font face="Optima" size="1">,
3;</p>
<p align="left">98-103.</font></p>
</td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Potentised and</p>
<p align="left">non-potentised</p>
<p align="left">dilutions are</p>
<p align="left">equally effective,</p>
<p align="left">but have different</p>
<p align="left">actions</font></p>
</td>
<td width="203" height="8">
<p align="left"><font face="Optima-Oblique" size="1">B</font><font face="Optima" size="1">asic
research</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><font face="Optima-Bold" size="1"><b>
<p align="left">Determination of the activity of</b></font> <b><font face="Optima-Bold" size="1">acid
phosphatase with cAMP at</font></b> <b><font face="Optima-Bold" size="1">various
potencies</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Harisch G.,</p>
<p align="left">Dittmann J.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">BM, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">,
1; 4-8.</font></td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Different effects on</font> <font face="Optima" size="1">enzymatic
activity</font></p>
</td>
<td width="203" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">In vitro </font></i><font face="Optima" size="1">study;</p>
<p align="left">basic research</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Contribution to study of the</p>
<p align="left">efficacy of homeopathic potencies</p>
<p align="left">of phosphorus</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">Gomez J.C.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">BT, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">,
2;</p>
<p align="left">53-57.</font></p>
</td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Effect of different</p>
<p align="left">potencies of</p>
<p align="left">phosphorus</font></p>
</td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Tests on guinea</p>
<p align="left">pigs</font></p>
</td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Determination of the activity of</p>
<p align="left">acid phosphatase in the presence</p>
<p align="left">of Ubichinon comp.</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Harisch G.,</p>
<p align="left">Dittmann J.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">,
4;</p>
<p align="left">188-194.</font></p>
</td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Effect of enzymatic</p>
<p align="left">activity of</p>
<p align="left">homeopathic</p>
<p align="left">medicine</font></p>
</td>
<td width="203" height="8"><font face="Optima-Oblique" size="1">B</font><font face="Optima" size="1">asic
research</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Biochemical efficacy of</p>
<p align="left">homeopathic and electronic</p>
<p align="left">preparations of D8 potassium</p>
<p align="left">cyanate</font></b></p>
</td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Dittmann J.,</p>
<p align="left">Kanapin H.,</p>
<p align="left">Harisch G.</font></p>
</td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">FKM, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">,
6;</p>
<p align="left">15-18.</font></p>
</td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Homeopathic</p>
<p align="left">potentisation is</p>
<p align="left">more effective than</p>
<p align="left">electronic</p>
<p align="left">potentisation</font></p>
</td>
<td width="203" height="8"><font face="Optima-Oblique" size="1">B</font><font face="Optima" size="1">asic
research</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Osteoporosis in vitro in rat tibiaderived</p>
<p align="left">osteoblasts is promoted</p>
<p align="left">by the homeopathic preparation,</p>
<p align="left">FMS Calciumfluor</font></b></td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Palermo C.,</p>
<p align="left">Filanti C.,</p>
<p align="left">Poggi S.,</p>
<p align="left">Manduca P.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Cell Biol Int</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">,</p>
<p align="left">23(1): 31-40.</font></td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Osteogenesis</p>
<p align="left">(trial with</p>
<p align="left">compound drug)</font></td>
</tr>
<tr>
<td width="171" height="32" rowspan="2"><b><font face="Optima-Bold" size="1">
<p align="left">Thin-layer chromatography (TLC)</p>
<p align="left">of homeopathic active</p>
<p align="left">constituents</font></b></td>
<td width="128" height="32" rowspan="2"><font face="Optima" size="1">Schmolz
M.</font></td>
<td width="84" height="32" rowspan="2"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">1999</font></b><font face="Optima" size="1">,
5;</p>
<p align="left">248-250.</font></td>
<td width="92" height="16"><font face="Optima" size="1">
<p align="left">Constituents of</font> <font face="Optima" size="1">Arnica
comp.-</font> <font face="Optima" size="1">Heel® ointment:</font> <font face="Optima" size="1">electrophoresis</font>
<font face="Optima" size="1">accelerates their</font> <font face="Optima" size="1">skin
penetration.</font> </td>
<td width="203" height="32"><font face="Optima" size="1">Basic research</font></td>
</tr>
<tr>
<td width="92" height="16"><font face="Optima" size="1">Effect of</font> <font face="Optima" size="1">homeopathic</font>
<font face="Optima" size="1">constituents on</font> <font face="Optima" size="1">enzymatic
activity.</font></td>
<td width="203" height="4"><font face="Optima" size="1">Basic research</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Efficacy of a potentised</p>
<p align="left">homeopathic drug in reducing</p>
<p align="left">cytotoxic effects produced by</p>
<p align="left">arsenic trioxide in mice</font></b></td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Datta S.,</p>
<p align="left">Mallick P.,</p>
<p align="left">Bukhsh A.R.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Complement Ther</p>
<p align="left">Med</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1999
</font></b><font face="Optima" size="1">Jan;</p>
<p align="left">7 (8): 62-75 </font><b><font face="Optima-Bold" size="1">(a).</font></b></td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Arsenic trioxide</p>
<p align="left">toxicity</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Efficacy of a potentised</p>
<p align="left">homeopathic drug in reducing</p>
<p align="left">cytotoxic effects produced by</p>
<p align="left">arsenic trioxide in mice</font></b></td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Datta S.,</p>
<p align="left">Mallick P.,</p>
<p align="left">Bukhsh A.R.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Complement Ther</p>
<p align="left">Med</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">1999
</font></b><font face="Optima" size="1">Sep;</p>
<p align="left">7 (3): 156-63 </font><b><font face="Optima-Bold" size="1">(b).</font></b></td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Arsenic trioxide</p>
<p align="left">toxicity</font></td>
</tr>
<tr>
<td width="171" height="8"><font face="Optima-Bold" size="1"><b>
<p align="left">Non-cytotoxic antiviral action of</b></font> <font face="Optima-Bold" size="1"><b>a
homeopathic drug</b></font></td>
<td width="128" height="8"><font face="Optima" size="1">Heine H.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Ärzteitschrift für</p>
<p align="left">Neturheilverfahre</font></i><font face="Optima" size="1">,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">2000</font></b><font face="Optima" size="1">; 41: 542-7.</font></td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Symbol" size="1">
<p align="left">ã </font><font face="Optima" size="1">interferon</p>
<p align="left">synthesis</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Efficacy of a potentised</p>
<p align="left">homeopathic drug in reducing</p>
<p align="left">cytotoxic effects produced by</p>
<p align="left">arsenic trioxide in mice</font></b></td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Kundu S.N.,</p>
<p align="left">Mitra K.,</p>
<p align="left">Khuda</p>
<p align="left">Bukhsh A.R.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Complement Ther</p>
<p align="left">Med </font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">2000
</font></b><font face="Optima" size="1">Sep;</p>
<p align="left">1 (3): 157-65.</font></td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Protective</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Arsenic trioxide</p>
<p align="left">toxicity</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Stimulatory effect of some plant</p>
<p align="left">extracts used in homeopathy on</p>
<p align="left">the phagocytosis induced</p>
<p align="left">chemiluminescence of</p>
<p align="left">polymorphonuclear leukocytes</font></b></td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Crocnan D.,</p>
<p align="left">Greabu M.,</p>
<p align="left">Olinescu R.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">Rocz Akad Med</p>
<p align="left">Biochemist</font></i><font face="Optima" size="1">, </font><b><font face="Optima-Bold" size="1">2000</font></b><font face="Optima" size="1">;</p>
<p align="left">45: 246-254.</font></td>
<td width="92" height="8"><b><font face="Optima-Bold" size="1">Stimulant</font></b></td>
<td width="203" height="8"><font face="Optima" size="1">
<p align="left">Phagocytosis</font></td>
</tr>
<tr>
<td width="171" height="8"><b><font face="Optima-Bold" size="1">
<p align="left">Difference between the efficacy</p>
<p align="left">of single potencies and chords</font></b></td>
<td width="128" height="8"><font face="Optima" size="1">
<p align="left">Dittmann J.,</p>
<p align="left">Harisch G.</font></td>
<td width="84" height="8"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">2000</font></b><font face="Optima" size="1">,
1;</p>
<p align="left">18-23.</font></td>
<td width="92" height="8"><font face="Optima" size="1">
<p align="left">Potency chords are</p>
<p align="left">more effective than</p>
<p align="left">single potencies</font></td>
<td width="203" height="8"><font face="Optima" size="1">Basic research</font></td>
</tr>
<tr>
<td width="171" height="28"><b><font face="Optima-Bold" size="1">
<p align="left">Influence of some homeopathic</p>
<p align="left">drugs on the catalytic activity of</p>
<p align="left">uricase, acid phosphatase and the</p>
<p align="left">cytosol glutathion-S-transferase</font></b></td>
<td width="128" height="28"><font face="Optima" size="1">
<p align="left">Dittmann J.,</p>
<p align="left">Kanapin H.,</p>
<p align="left">Harisch G.</font></td>
<td width="84" height="28"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">2000</font></b><font face="Optima" size="1">,
3;</p>
<p align="left">125-131</font></td>
<td width="92" height="28"><font face="Optima" size="1">
<p align="left">Effect of D8</p>
<p align="left">potencies on three</p>
<p align="left">different enzymatic</p>
<p align="left">systems</font></td>
<td width="203" height="28"><font face="Optima" size="1">Basic research</font></td>
</tr>
<tr>
<td width="171" height="37"><b><font face="Optima-Bold" size="1">
<p align="left">Influence of some homeopathic</p>
<p align="left">drugs on the catalytic activity of</p>
<p align="left">cAMP-dependent protein kinases</font></b></td>
<td width="128" height="37"><font face="Optima" size="1">
<p align="left">Dittmann J.,</p>
<p align="left">Kanapin H.,</p>
<p align="left">Harisch G.</font></td>
<td width="84" height="37"><i><font face="Optima-Oblique" size="1">
<p align="left">BM, </font></i><b><font face="Optima-Bold" size="1">2000</font></b><font face="Optima" size="1">,
6;</p>
<p align="left">289-296.</font></td>
<td width="92" height="37"><font face="Optima" size="1">
<p align="left">Effect of different</p>
<p align="left">potencies of 5</p>
<p align="left">substances on</p>
<p align="left">enzymatic activity</font></td>
<td width="203" height="37"><font face="Optima" size="1">Basic research</font></td>
</tr>
<tr>
<td width="171" height="38"><b><font face="Optima-Bold" size="1">
<p align="left">Neuroprotection from glutamate</p>
<p align="left">toxicity with ultra-low dose</p>
<p align="left">glutamate</font></b></td>
<td width="128" height="38">
<p align="left"><font face="Optima" size="1">Jonas W.,</p>
<p align="left">Lin Y.,</p>
<p align="left">Zortella F.</font></td>
<td width="84" height="38"><i><font face="Optima-Oblique" size="1">
<p align="left">Neuroreport</font></i><font face="Optima" size="1">,</p>
</font><b><font face="Optima-Bold" size="1">
<p align="left">2001 </font></b><font face="Optima" size="1">Feb 92; 12</p>
<p align="left">(2): 335-9.</font></td>
<td width="92" height="38"><b><font face="Optima-Bold" size="1">Protective</font></b></td>
<td width="203" height="38"><font face="Optima" size="1">Glutamate
toxicity</font></td>
</tr>
</table>
</div>
<font face="Optima" size="1">
<p align="left">&nbsp;</p>
<p align="left">KEY: BT = Biomedical Therapy</p>
<p align="left">BM = Biologische Medizin</p>
<p align="left">FKM = Forschung Komplementär Medizin</p>
</font></font></font></font></font></font></font></font>[[User:Ramaanand|Ramaanand]] ([[User talk:Ramaanand|talk]]) 02:14, 17 March 2008 (UTC)Dr.Jhingadé

Revision as of 02:14, 17 March 2008

Please stop adding nonsense to Wikipedia. It is considered vandalism. If you were just trying to experiment, then use the sandbox instead. Thank you. --W(t) 02:51, 2005 May 23 (UTC)

Please stop. If you continue to vandalize pages, you will be blocked from editing Wikipedia. Mindspillage (spill yours?) 02:51, 23 May 2005 (UTC)[reply]

Please don't move articles to strange names where no one will expect them. NoAccount

I deleted User:Arion/monobook.js since it was clearly meant to assist in moving articles to improper names. -- Jitse Niesen (talk) 11:32, 4 September 2005 (UTC)[reply]

Please put this on the Talk:Homeopathy Page and mention it is posted by me

Dear Scientizzle,
Please put this on the Talk:Homeopathy Page and mention it is posted by me (or else the others may think I've bribed you); I'm not yet able to post there directly myself because the Page is semi-writeprotected.

Here are some of the studies/clinical trials:-

STUDIES OF THE ACTIVITY OF HOMEOPATHIC MEDICINES

ORIGINAL/TRANSLATED TITLE AUTHOR(S) PUBLICATION ACTIVITY STUDY

Inhibition of lymphoblast transformation test (LTT) in phytohaemagglutinin (PHA) with Phytolacca americana in homeopathic dilution

Colas H.,

Aubin M.,

Picard P.,

Lebecq J.C.

Ann. Homéopat.

Fr., 1975, 6: 1-11.

Inhibitory

Lymphoblast

transformation

Inquiry into the limits of biological effects of chemical compounds in tissue culture. I. Low dose effects of mercure chloride

Mansvelt J.D.,

van Amons E.

Z. Naturtorschung,

       

1975, 30:

643-649.

Inhibitory

Lymphocyte

growth

The effects of Belladonna and Ferrum phosphoricum on the chemoluminescence of human poly-morphonuclear neutrophils

Poitevin B.,

Aubin M.,

Royer J.F.

Ann. Homéop. Fr.,

       

1983, 3: 5-12.

Inhibitory

Radical release

Effect of aconitum and veratrum

on the isolated perfused heart of

the common eel (Anguilla anguilla)

Pennec J.P.,

Aubin M.

Comp. Biochem.

Physiol., 1984,

776: 367-369.

Protective Aconitine toxicity

Elements of homeopathic

pharmacology

Aubin M.

Homéopathie

Franç., 1984, 72:

231- 235

Protective Aconitine toxicity

The effect of homeopathic

preparations on the phagocyte

activity of granulocytes. In vitro

tests and double-blind controlled

trials

Wagner H.,

Jurcic K.,

Doenicke A.,

Rosenhuber E.,

Behrens N.

Arzneim.

Forsch./Drug Res.,

       

1986, 36:

1424-1425.

Stimulant Phagocytosis

Approach to quantitative analysis

of the effect of Apis mellifica on

the degranulation of human

basophils cultivated in vitro

Poitevin B.,

Aubin M.,

Benveniste J.

Innov. Tech. Biol.

Med., 1986, 7:

64-68.

Inhibitory

Basophil

degranulation

In vitro stimulation of human granulocytes and lymphocytes by pico- and femtogram quantities of cytostatic agents

Wagner H.,

Kreher B.,

Jurcic K.

Arzneim. Forsch./Drug Res., 1988, 38: 273-275.

Stimulant

Lymphocyte

growth

Human basophil degranulation triggered by very dilute antiserum against IgE

Davenas E., Beauvais F., Amara J., Robinson M., Miadonna A., Tedeschi A., Pomeranz B., Fortner P., Belon P., Sainte-Laudy J., Poitevin B., Benveniste J.

Nature, 1988,

333: 816-818.

Stimulant

Basophils

In vitro immunological

degranulation of human basophils

is modulated by lung histamine

and Apis mellifica

Poitevin B.,

Davenas E.,

Benveniste J.

Brit. J. Clin.

Pharmacol., 1988,

25: 439-444.

Inhibitory

Basophil

degranulation

Cytotoxic agents as

immunomodulators

Wagner H.,

Kreher B.

Proc. of the 3rd

GIRI meeting,

Paris, 1989, 31-

46.

Stimulant

Lymphocyte

growth

Contributions of fundamental

research in homeopathy

Boiron J.,

Belon P.

Berl. J. Res. Hom.,

       

1990, 1: 34-35.

Inhibitory

Basophil

degranulation

Synergism of action between

indoleacetic acid (IAA) and highly

diluted solutions of CaCO3 on the

growth of oat coleoptiles

Bornoroni C.

Berl. J. Res. Hom.,

       

1991, 1 (4/5):

275-278.

Stimulant

Growth of plant

cells

Study of the action of

Hahnemannian dilutions of

mercury chloride on the mitotic

index in animal cell cultures.

Boiron J.,

Abecassis J.,

Cotte J.,

Bernard A.M.

Ann. Homéop.

Fr., 1991, 23:

43-49.

Protective Hg toxicity

Dual effects of formylpeptides on

the adhesion of endotoxin-primed

human neutrophils

Bellavite P.,

Chirumbolo S.,

Lippi G.,

Andrioli G.,

Bonazzi L.,

Ferro I.

Cell. Biochem.

Funct., 1993, 11:

231-239.

Inhibitory

Cell adhesion

(bact. pept.

10-8-10-9)

Effects of homeopathic

preparations of organic acids and

of minerals on the oxidative

metabolism of human neutrophils

Chirumbolo S.,

Signorini A.,

Bianchi I.,

Lippi G.,

Bellavite P.

Br. Hom. J., 1993,

82: 227-244.

Inhibitory

Leucocyte

activation

(metabolism)

Platelets/endothelial cells

interactions in presence of

acetylsalicylic acid at ultra low

dose

Doutremepuich

C.,

Lalanne M.C.,

Ramboer I.,

Sertillanges

M.N.,

De Seze O.

Omeomed 92 (C.

Bornoroni, ed.),

       

1993, Editrice

Compositori,

Bologna:

109-115.

Inhibitory

Prostacyclin

release

Effect of high dilutions of epidermal

growth factor (EGF) on in vitro

       

proliferation of keratinocyte and

fibroblast cell lines

Fougeray S.,

Moubry K.,

Vallot N.,

Bastide M.

Br. Hom. J., 1993,

82: 124-125.

Inhibitory

Growth of

keratinocytes

Effects of different homeopathic

potencies of Lachesis on

lymphocyte cultures obtained

from rabbit blood

Enbergs H.,

Arndt G.

Biol. Tier., 1993,

4.

Stimulant

Mitotic and

immunostimulating

activity (bact. pept

10-5-10-6)

The effect of homeopathic

potencies of housedust mite on

the migration of house-dust sensitive

human leukocytes

Gibson S.L.,

Gibson R.G.

Complement.

Ther. Med., 1996,

4: 169-171.

Stimulant

Leucocyte

chemotaxis

The effects of Nux vomica

Homaccord and Atropinum comp.

on intestinal activity in vitro

Kanui T.I.,

Enbergs H.

Biol. Tier., 1996/1,

43-47.

Stimulant

Contraction of

intestinal muscles

Application of flow cytometry to

the analysis of the

immunosuppressive effect of

histamine dilutions on human

basophil action: effect of

cimetidine

Sainte-Laudy J.,

Belon P.

Inflamm. Res.,

       

1997, 46:

S27-S28.

Inhibitory

Basophil

degranulation

Effects of Podophillum pellatum

compounds in various

preparations and dilutions on

human neutrophil functions in

vitro

Chirumbolo S.,

Conforti A.,

Lussignoli S.,

Metelmann H.

et Al.

Br. Hom. J., 1997;

86-16.

Inhibitory

Release of

superoxides

In vivo and in vitro studies on the

efficiency of potentized and nonpotentized

substances

Harisch G.,

Dittmann J.

BT, 1997, 2;

40-46.

Difference between

potentised and

non-potentised

substances

In vivo and in

vitro study; basic

research

Experiments with the effects of

Ubichinon-Injeel and strong

Ubichinon-Injeel on an acellular

system

Harisch G.,

Dittmann J.

BM, 1997, 3;

99-104.

Different effects of

associations of

various potencies and

individual potencies

In vitro study;

basic research

Efficacy of the homeopathic drugs

Suis and Arnica comp.-Heel® on

lymphocyte and phagocyte

activity

Enbergs H.

BM, 1998, 1;

3-11.

Effect of

organotherapeutics

and Arnica comp. -

Heel® on immune

system cells

In vitro study;

basic research

Influence of dilutions and

potencies of cAMP on different

enzymatic systems

Harisch G.,

Dittmann J.

BM, 1998, 2;

55-62.

Effects of dilutions

and potencies of

cAMP on some

enzymatic activities

In vitro study;

basic research

Studies of the principles of

homeopathy; the changeover

from in vivo to in vitro

       

experimental research

Harisch G.,

Dittmann J.

BM, 1998, 3;

98-103.

Potentised and

non-potentised

dilutions are

equally effective,

but have different

actions

Basic research

Determination of the activity of acid phosphatase with cAMP at various potencies

Harisch G.,

Dittmann J.

BM, 1999, 1; 4-8.

Different effects on enzymatic activity

In vitro study;

basic research

Contribution to study of the

efficacy of homeopathic potencies

of phosphorus

Gomez J.C.

BT, 1999, 2;

53-57.

Effect of different

potencies of

phosphorus

Tests on guinea

pigs

Determination of the activity of

acid phosphatase in the presence

of Ubichinon comp.

Harisch G.,

Dittmann J.

BM, 1999, 4;

188-194.

Effect of enzymatic

activity of

homeopathic

medicine

Basic research

Biochemical efficacy of

homeopathic and electronic

preparations of D8 potassium

cyanate

Dittmann J.,

Kanapin H.,

Harisch G.

FKM, 1999, 6;

15-18.

Homeopathic

potentisation is

more effective than

electronic

potentisation

Basic research

Osteoporosis in vitro in rat tibiaderived

osteoblasts is promoted

by the homeopathic preparation,

FMS Calciumfluor

Palermo C.,

Filanti C.,

Poggi S.,

Manduca P.

Cell Biol Int, 1999,

23(1): 31-40.

Stimulant

Osteogenesis

(trial with

compound drug)

Thin-layer chromatography (TLC)

of homeopathic active

constituents

Schmolz M.

BM, 1999, 5;

248-250.

Constituents of Arnica comp.- Heel® ointment: electrophoresis accelerates their skin penetration.

Basic research
Effect of homeopathic
       constituents on enzymatic
activity.
Basic research

Efficacy of a potentised

homeopathic drug in reducing

cytotoxic effects produced by

arsenic trioxide in mice

Datta S.,

Mallick P.,

Bukhsh A.R.

Complement Ther

Med, 1999 Jan;

7 (8): 62-75 (a).

Protective

Arsenic trioxide

toxicity

Efficacy of a potentised

homeopathic drug in reducing

cytotoxic effects produced by

arsenic trioxide in mice

Datta S.,

Mallick P.,

Bukhsh A.R.

Complement Ther

Med, 1999 Sep;

7 (3): 156-63 (b).

Protective

Arsenic trioxide

toxicity

Non-cytotoxic antiviral action of a homeopathic drug

Heine H.

Ärzteitschrift für

Neturheilverfahre,

       

2000; 41: 542-7.

Stimulant

ã interferon

synthesis

Efficacy of a potentised

homeopathic drug in reducing

cytotoxic effects produced by

arsenic trioxide in mice

Kundu S.N.,

Mitra K.,

Khuda

Bukhsh A.R.

Complement Ther

Med , 2000 Sep;

1 (3): 157-65.

Protective

Arsenic trioxide

toxicity

Stimulatory effect of some plant

extracts used in homeopathy on

the phagocytosis induced

chemiluminescence of

polymorphonuclear leukocytes

Crocnan D.,

Greabu M.,

Olinescu R.

Rocz Akad Med

Biochemist, 2000;

45: 246-254.

Stimulant

Phagocytosis

Difference between the efficacy

of single potencies and chords

Dittmann J.,

Harisch G.

BM, 2000, 1;

18-23.

Potency chords are

more effective than

single potencies

Basic research

Influence of some homeopathic

drugs on the catalytic activity of

uricase, acid phosphatase and the

cytosol glutathion-S-transferase

Dittmann J.,

Kanapin H.,

Harisch G.

BM, 2000, 3;

125-131

Effect of D8

potencies on three

different enzymatic

systems

Basic research

Influence of some homeopathic

drugs on the catalytic activity of

cAMP-dependent protein kinases

Dittmann J.,

Kanapin H.,

Harisch G.

BM, 2000, 6;

289-296.

Effect of different

potencies of 5

substances on

enzymatic activity

Basic research

Neuroprotection from glutamate

toxicity with ultra-low dose

glutamate

Jonas W.,

Lin Y.,

Zortella F.

Neuroreport,

       

2001 Feb 92; 12

(2): 335-9.

Protective Glutamate toxicity

 

KEY: BT = Biomedical Therapy

BM = Biologische Medizin

FKM = Forschung Komplementär Medizin

Ramaanand (talk) 02:14, 17 March 2008 (UTC)Dr.Jhingadé[reply]